Cancer of Unknown Primary
📧 Sign up to get email alerts when something new happens for Cancer of Unknown Primary.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: PaCIFiC-CUP Classifies Cancer of Unknown Primary
Clinical trial update indicating the PaCIFiC-CUP program is currently recruiting to classify cancer of unknown primary.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY) [Phase 2]
A Phase 2a, single-dose, open-label study evaluating Pegsitacianine for intraoperative fluorescence imaging to detect cancer in patients wit…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Enabling Genomic Testing in Cancer of Unknown Primary
The clinical trial Enabling Genomic Testing in Cancer of Unknown Primary is currently recruiting, sponsored by The Christie NHS Foundation T…
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: Sintilimab in Cancer of Unknown Primary [Phase 2]
Phase 2 trial of sintilimab in cancer of unknown primary has completed, with results posted.
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary [Phase 2]
Phase II clinical trial evaluating Lu-177 FAP-2286 for carcinoma of unknown primary; the study status is NOT_YET_RECRUITING.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary [Phase 2]
Phase 2 trial assessing dual immune checkpoint inhibition with atezolizumab and tiragolumab in cancer of unknown primary; the study is activ…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: The NorCUP Trial: Improving Prognosis and Personalized Treatment in Cancer of Unknown Primary (CUP) [NA]
The NorCUP trial is investigating prognosis and personalized treatment for cancer of unknown primary, and is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Evaluating the Predictive Capability of Transcriptomic Profiling for Identifying the Primary Site of Metastatic Tumors
A clinical trial update from Fudan University is evaluating whether transcriptomic profiling can predict the primary site of metastatic tumo…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Intensive Cancer Screening After Cryptogenic Stroke [NA]
This Ottawa Hospital Research Institute trial is evaluating intensive cancer screening to detect occult cancer in patients after cryptogenic…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary [Phase 2]
Phase 2 trial update evaluating pucotenlimab in combination with MRG002 for HER2-positive cancer of unknown primary; study is not yet recrui…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: Contrast Enhanced Mammography in the Evaluation of Cancer of Unknown Primary Syndrome
This clinical trial investigates the use of contrast-enhanced mammography to evaluate cancer of unknown primary syndrome, with enrollment by…
-
CLINICAL_TRIALS research · 2025-02-12Clinical Trial Update: [18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin [NA]
This clinical trial assesses the use of the [18F]F-FAPI PET-CT tracer to identify carcinoma of unknown primary origin. It is currently recru…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Surgeon-performed Intraoperative Transoral Ultrasound for Cancer of Unknown Primary [NA]
Update on a completed trial evaluating surgeon-performed intraoperative transoral ultrasound for cancer of unknown primary.
-
CLINICAL_TRIALS trial_result · 2022-04-20Clinical Trial Update: PD-1 Inhibitor and Nab-paclitaxel and Bevacizumab in CUP [Phase 2]
Phase 2 trial evaluating a PD-1 inhibitor with nab-paclitaxel and bevacizumab for cancer of unknown primary (CUP).
-
CLINICAL_TRIALS trial_result · 2022-02-15Clinical Trial Update: Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary [Phase 2]
Phase 2 trial updating tislelizumab plus chemotherapy for bone metastases of unknown primary; disease specifics not fully defined in the sni…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
The trial evaluated outcomes of FoundationOne-directed therapy in cancer of unknown primary and has completed, providing results on genomic-…
-
CLINICAL_TRIALS trial_result · 2016-06-07Clinical Trial Update: Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying Lesions [NA]
A clinical trial comparing Modified Wet Suction Technique versus Dry Suction Technique for EUS-FNA of solid lesions; the study status is cur…
-
CLINICAL_TRIALS trial_result · 2016-06-01Clinical Trial Update: Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary [Phase 1, Phase 2]
Phase 1/2 trial evaluating a capecitabine-carboplatin-paclitaxel regimen for solid tumors, including adenocarcinoma of unknown primary; the …
-
CLINICAL_TRIALS trial_result · 2012-08-15Clinical Trial Update: Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)
A completed cost-effectiveness study evaluating the miRview Mets diagnostic test in patients with cancer of unknown primary.
-
CLINICAL_TRIALS research · 2011-11-10Clinical Trial Update: CUP Project PET/CT [Phase 4]
Update on a Phase 4 clinical trial investigating PET/CT for cancer of unknown primary (CUP) at Odense University Hospital.
-
CLINICAL_TRIALS trial_result · 2009-05-14Clinical Trial Update: Paclitaxel/Carboplatin With or Without Cetuximab in CUP [Phase 2]
Phase 2 clinical trial evaluating paclitaxel/carboplatin with or without cetuximab for cancers of unknown primary (CUP).